Literature DB >> 1856476

Application of hepatitis B virus (HBV) DNA sequence polymorphisms to the study of HBV transmission.

H J Lin1, C L Lai, I J Lauder, P C Wu, T K Lau, M W Fong.   

Abstract

Short sequences in hypervariable regions of the hepatitis B virus (HBV) genome can be used to identify different strains, providing a novel approach to the study of HBV transmission. The nucleotide sequence in positions 2551-2650 (1:EcoRI site) was determined for serum HBV DNA from 96 Chinese children living in Hong Kong and from 38 of their parents. HBV DNA was extracted and sequenced after amplification with the polymerase chain reaction, using as primers oligonucleotides corresponding to two conserved sequences. Among 82 unrelated children, 32 HBV DNA variants were present. One sequence was present in 33 children and 31 variants were found among the other 49. Siblings within each of nine families had the same variant; in three families siblings had different variants. Six of the eight fathers and 28 of the 30 mothers had HBV DNA sequences identical to those of their offspring. A total of 34 variants were found among the 134 individuals. The hypothesis of random assortment of sequences in parents and children was rejected (P less than .00005). Thus, this new approach proves the occurrence of intrafamilial transmission of HBV among Chinese.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1856476     DOI: 10.1093/infdis/164.2.284

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  2 in total

1.  Low level virus replication in infants with vertically transmitted fulminant hepatitis and their anti-HBe positive mothers.

Authors:  E Schaefer; H Koeppen; S Wirth
Journal:  Eur J Pediatr       Date:  1993-07       Impact factor: 3.183

Review 2.  Applications of next-generation sequencing analysis for the detection of hepatocellular carcinoma-associated hepatitis B virus mutations.

Authors:  I-Chin Wu; Wen-Chun Liu; Ting-Tsung Chang
Journal:  J Biomed Sci       Date:  2018-06-02       Impact factor: 8.410

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.